Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessStocks

Sun Pharma Advanced slips 3% after US firm alleges infringement of patent

The company believes that this lawsuit is without merit and will vigorously defend against these allegations.

August 21, 2019 / 09:44 AM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Shares of Sun Pharma Advanced Research Company declined more than 3 percent in the early trade on August 21 after a US firm filed a complaint against the company in the US District Court.

A complaint has been filed by Abraxis Biosciences LLC in the US District Court alleging that SPARC’s filing of New Drug Application (NDA) for Taclantis injection (Paclitaxel Injection Concentrate for Suspension) is an act of infringement of the Orange Book listed patents for Abraxane, as per company release.

The company believes that this lawsuit is without merit and will vigorously defend it.

SPARC

At 0926 hrs, Sun Pharma Advanced Research Company was quoting at Rs 151.70, down Rs 2.50, or 1.62 percent on the BSE.

The share touched its 52-week high of Rs 413.40 and its 52-week low of Rs 107 on 31 August 2018 and 9 July 2019, respectively.

Currently, it is trading 63.13 percent below its 52-week high and 42.43 percent above its 52-week low.

Moneycontrol News
first published: Aug 21, 2019 09:42 am

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347